Abstract:Background & aims: Non-small cell lung cancer (NSCLC) accounts for about 80% of lung cancer diagnoses across the world. Despite recent appreciable improvements in treatment plans for patients with NSCLC, the prognosis for those with the cancer still remains poor. Recently, a growing number of studies have shown that N-myristoyltransferases (NMTs) may be critical in carcinogenesis, however, the functional and clinical significance of this pathway in NSCLC remains unclear and requires further research. Methods: Initially, we evaluated the expression levels of NMT1 or NMT2 in a clinical cohort comprising of 303 paired primary NSCLC tissues and matched normal mucosae by using ELISA. We subsequently performed a tissue microarray analysis (TMA) to confirm its expression pattern in an independent validation cohort (n = 78). Then, we used a publicly available KM plotter database (n = 1921) to evaluate the prognostic impact of NMT1 and NMT2 in NSCLC. Lastly, a series of in-vitro molecular/cellular and animal experiments were performed for mechanistic understanding of the role of N-myristoyltransferases in NSCLC. Results: Our ELISA data revealed that the expression level of NMT1 and NMT2 was down-regulated in tumor tissues (n = 303, P < 0.0001), which was confirmed in an independent validation cohort by TMA (n = 78, P = 0.014 for NMT1 and P < 0.0001 for NMT2). On the other hand, patients with low expression of NMT1 or NMT2 had shorter overall survival (P = 0.013, HR = 0.85 for NMT1; P = 0.00059, HR = 0.8, for NMT2). Mechanistically, we revealed that the interaction and co-localization of NMT1 and NMT2 in NSCLC, and N-terminus of NMT1 and NMT2 was observed to be crucial for their interaction as well as for their catalytic activity. Moreover, we found that NMT1 can significantly promote the expression of NMT2 by enhancing its stability. We corroborated these findings by performing functional assays in which the knockout of NMT1 and NMT2 resulted in enhanced cell proliferation, migration and invasion as well as increased tumor xenograft growth. In addition, we identified miR-182 as a novel regulator of both NMT1 and NMT2. More specifically, the overexpression or inhibition of miR-182 modulated globe N-myristoylation level, contributed to phenotypic alterations in NSCLS cells. Conclusions: NMT1 and NMT2 can act as potential tumor suppressors in NSCLC, and the inhibition of miR-182 expression or therapeutic NMTs replenishment may be a promising treatment option for patients with NSCLC.

Mirna-204 Suppresses Human Non-small Cell Lung Cancer by Targeting ATF2

Mir-144-5p Enhances The Radiosensitivity Of Non-Small-Cell Lung Cancer Cells Via Targeting Atf2

Microrna-370 Inhibits The Progression Of Non-Small Cell Lung Cancer By Downregulating Oncogene Traf4

Mir-194 Inhibits the Proliferation, Invasion, Migration, and Enhances the Chemosensitivity of Non-Small Cell Lung Cancer Cells by Targeting Forkhead Box A1 Protein

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

Decreased Expression of Mir216a Contributes to Non-Small-Cell Lung Cancer Progression

N-mytistoyltransferase 1 and 2 Are Potential Tumor Suppressors and Novel Targets of Mir-182 in Human Non-Small Cell Lung Carcinomas.

Tumor Suppressor Mir-22 Suppresses Lung Cancer Cell Progression Through Post-Transcriptional Regulation of Erbb3

Mir-182 Suppresses Invadopodia Formation and Metastasis in Non-Small Cell Lung Cancer by Targeting Cortactin Gene

Data from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Mir-145 Suppresses the Proliferation, Invasion and Migration of NSCLC Cells by Regulating the BAX/BCL-2 Ratio and the Caspase-3 Cascade

Inhibition of Inflammation and Infiltration of M2 Macrophages in NSCLC Through the ATF3/CSF1 Axis: Role of Mir‐27a‐3p

Mir-215 Functions As a Tumor Suppressor and Directly Targets ZEB2 in Human Non-Small Cell Lung Cancer

Mir-204 Regulates the Biological Behavior of Breast Cancer MCF-7 Cells by Directly Targeting FOXA1

Mir-592 Functions As a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Targeting SOX9.

Mir-199A-3p/5p Regulate Tumorgenesis Via Targeting Rheb in Non-Small Cell Lung Cancer

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.

Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2

The Suppressive Role of Mir-542-5p in NSCLC: the Evidence from Clinical Data and in Vivo Validation Using a Chick Chorioallantoic Membrane Model

Mir‑146a‑5p Targets TCSF and Influences Cell Growth and Apoptosis to Repress NSCLC Progression